Concepedia

Ronald C. Wielage

RC

8

Publications

243

Citations

8

H-Index

2008

Active since

Affiliations

Medical Decision Modeling (United States)(Current)

Eli Lilly (Germany)

Regenstrief Institute

Astellas Pharma (United States)

Purdue University West Lafayette

Ronald C. Wielage is an author at Medical Decision Modeling (United States) specializing in medicine, health economics, and health services research.

Top concepts

Publications per year

2008–2020

8

Publications

8

Association of Anticholinergic Burden with Cognitive Impairment and Health Care Utilization Among a Diverse Ambulatory Older Adult Population

Noll L. Campbell, Anthony J. Perkins, Pamela Bradt et al. · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · 2016 · 100 citations · Full text

Cost-Utility Analysis of Duloxetine in Osteoarthritis: A US Private Payer Perspective

Ronald C. Wielage, Megha Bansal, J. Scott Andrews et al. · Applied Health Economics and Health Policy · 2013 · 33 citations

, , +11

Mirabegron for the treatment of overactive bladder: cost-effectiveness from US commercial health-plan and Medicare Advantage perspectives

Ronald C. Wielage, Sinem Perk, Noll L. Campbell et al. · Journal of Medical Economics · 2016 · 29 citations

The Cost-Effectiveness of Duloxetine in Chronic Low Back Pain: A US Private Payer Perspective

Ronald C. Wielage, Megha Bansal, J. Scott Andrews et al. · Value in Health · 2013 · 28 citations

, , +10

Comparative analysis of long-term organ damage in patients with systemic lupus erythematosus using belimumab versus standard therapy: a post hoc longitudinal study

Murray B. Urowitz, Robert L. Ohsfeldt, Ronald C. Wielage et al. · Lupus Science & Medicine · 2020 · 16 citations · Full text

Rows per page

1–5 of 8